RegistryReach
Drug & device makers paid U.S. providers $2.89 billion in 2025.
Every payment a manufacturer makes to a physician is public record under the Sunshine Act. Here's where the money went, by practice state and specialty, refreshed from the federal Open Payments release.
Where the money went
Who gets paid: top specialties
Who's writing the checks: top manufacturers
Explore by state
Explore by specialty
Common questions
How can I see what drug companies paid a specific doctor?
Every payment is public under the Sunshine Act. The federal Open Payments site (openpaymentsdata.cms.gov) lets you look up one physician at a time. RegistryReach aggregates the same data so you can search by specialty, state, and payment level across 5.6M providers at once, and download the results.
Who paid U.S. physicians the most in 2025?
AbbVie led all manufacturers at $198M in general payments. Seven of the top ten payers are device companies: Stryker, Medtronic, Arthrex, Boston Scientific, Zimmer Biomet, DePuy Synthes, and Intuitive Surgical. The full ranking is in our manufacturer league table.
Which medical specialty receives the most industry money?
Orthopaedic surgery, at $333M in 2025, followed by internal medicine ($208M) and dermatology ($103M). Device money concentrates in the operating room. See the specialty breakdowns.
How do I get a list of providers by specialty and state with contact information?
RegistryReach Lists lets you filter 5.6M registry-verified providers by discipline, state, specialty, and industry payments, preview the exact count free, then download a CSV with verified practice contacts and each provider's payment history. Build a list.
Is this data legal to use?
Yes. Open Payments and NPPES are public federal datasets published specifically for transparency. RegistryReach aggregates business practice information only; no patient data is involved anywhere.